IL284670A - Skin renewing and healing mixture of peptide components and its use - Google Patents

Skin renewing and healing mixture of peptide components and its use

Info

Publication number
IL284670A
IL284670A IL284670A IL28467021A IL284670A IL 284670 A IL284670 A IL 284670A IL 284670 A IL284670 A IL 284670A IL 28467021 A IL28467021 A IL 28467021A IL 284670 A IL284670 A IL 284670A
Authority
IL
Israel
Prior art keywords
peptide components
healing mixture
renewing
skin
skin renewing
Prior art date
Application number
IL284670A
Other languages
Hebrew (he)
Original Assignee
Globetech Innovation S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Globetech Innovation S R O filed Critical Globetech Innovation S R O
Publication of IL284670A publication Critical patent/IL284670A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
IL284670A 2019-01-21 2021-07-07 Skin renewing and healing mixture of peptide components and its use IL284670A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ201934A CZ308845B6 (en) 2019-01-21 2019-01-21 Pharmaceutical composition of topically healing peptide components for use in the topical treatment of skin defects and / or for topical wound healing
PCT/IB2020/050418 WO2020152568A1 (en) 2019-01-21 2020-01-20 Skin renewing and healing mixture of peptide components and its use

Publications (1)

Publication Number Publication Date
IL284670A true IL284670A (en) 2021-08-31

Family

ID=71736281

Family Applications (1)

Application Number Title Priority Date Filing Date
IL284670A IL284670A (en) 2019-01-21 2021-07-07 Skin renewing and healing mixture of peptide components and its use

Country Status (8)

Country Link
EP (1) EP3914279A1 (en)
JP (1) JP7193662B2 (en)
KR (1) KR20210120026A (en)
CN (1) CN113301910B (en)
CZ (1) CZ308845B6 (en)
IL (1) IL284670A (en)
SG (1) SG11202107397PA (en)
WO (1) WO2020152568A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113480601B (en) * 2021-07-01 2022-09-23 中国医学科学院放射医学研究所 Copper ion chelated self-assembled polypeptide nano hydrogel and preparation method thereof
WO2023015533A1 (en) * 2021-08-12 2023-02-16 深圳市维琪医药研发有限公司 Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
CN113662877A (en) * 2021-09-07 2021-11-19 肽领生物科技(上海)有限公司 Preparation method of blue ketone peptide repair essence
CN114349823B (en) * 2022-01-25 2023-07-18 杭州禾泰健宇生物科技有限公司 Double-targeting multifunctional peptoid compound, and preparation method and application thereof
CN114848887B (en) * 2022-05-20 2023-08-25 诺一迈尔(苏州)生命科技有限公司 Nanofiber dressing and preparation method thereof
CN116098828A (en) * 2022-12-21 2023-05-12 深圳市维琪科技股份有限公司 New use of tetrapeptide derivatives for preparing composition for skin repair and tightening

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US5981606A (en) 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5149691A (en) 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5318973A (en) 1993-06-07 1994-06-07 Vyzkumny Ustav Pro Farmacii A Biochemii Neuroprotective composition for preventing or treating of central nervous system impairment
US6800286B1 (en) 1998-08-19 2004-10-05 The Regents Of The University Of Colorado Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
WO2003013569A2 (en) * 2001-07-27 2003-02-20 The Board Of Regents, The University Of Texas System Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
WO2003030926A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
US20050209131A1 (en) * 2001-11-16 2005-09-22 Singleton Laura C Composition containing peptides complexed with a copper ion
NZ547140A (en) * 2003-10-22 2009-09-25 Encelle Inc Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
EP1640041A3 (en) * 2004-09-24 2006-05-24 Henkel Kommanditgesellschaft auf Aktien Cosmetic and dermatological composition for the treatment of aging or photodamaged skin
AU2006290251B2 (en) * 2005-09-13 2011-12-08 Abburi Ramaiah Agonist peptides of basic fibroblast growth factor (BFGF) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing
CA2802471A1 (en) * 2010-06-14 2011-12-22 Gene Signal International Sa Novel peptides for wound healing
JP2014532713A (en) 2011-11-02 2014-12-08 ハルシオン，インコーポレイテッド Wound treatment methods and compositions
CA2898717C (en) * 2013-02-14 2019-01-08 Helix Biomedix, Inc. Short bio-active peptides for promoting wound healing
MX360649B (en) 2013-03-13 2018-11-12 Anteis Sa Peptides for skin rejuvenation and methods of using the same.
KR101689875B1 (en) * 2014-08-28 2016-12-26 (주)셀아이콘랩 Cosmetic composition for treating atopic dermatitis containing mixtures of peptide and amino acid
CN108883048A (en) 2016-02-04 2018-11-23 阿拉斯廷护肤公司 For invasive and composition and method of the procedural skin care of Noninvasive

Also Published As

Publication number Publication date
CZ308845B6 (en) 2021-07-07
WO2020152568A1 (en) 2020-07-30
CZ201934A3 (en) 2020-07-29
JP2022513418A (en) 2022-02-07
SG11202107397PA (en) 2021-08-30
EP3914279A1 (en) 2021-12-01
KR20210120026A (en) 2021-10-06
CN113301910A (en) 2021-08-24
JP7193662B2 (en) 2022-12-20
CN113301910B (en) 2023-02-03

Similar Documents

Publication Publication Date Title
IL284670A (en) Skin renewing and healing mixture of peptide components and its use
IL277146A (en) Amino acid compounds and methods of use
EP4019530A4 (en) Peptide having activity of improving skin condition and use thereof
IL275777A (en) Improved peptide pharmaceuticals for treatment of nash and other disorders
IL282026A (en) Amino acid compounds and methods of use
IL292810A (en) Therapeutic compounds and methods of use
SG11201912110YA (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
EP3638298A4 (en) Peptide immunogens from the c-terminal end of alpha-synuclein protein and formulations thereof for treatment of synucleinopathies
IL282205A (en) Disulfide bond stabilized polypeptide compositions and methods of use
IL290910A (en) Modified tff2 polypeptides containing compositions and methods of use thereof
EP4069274A4 (en) Peptide conjugates and methods of use
IL286697A (en) Neuregulin-4 compounds and methods of use
IL281377A (en) Nanoparticle formulations and methods of use for alpha connexin c-terminal peptides
EP3962428A4 (en) Therapeutic compression system and methods of use
ZA202100587B (en) Peptide compounds and therapeutic uses of same
SG11202112487QA (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
EP3650461A4 (en) Novel peptide exhibiting effect of releasing hematopoietic stem cells into blood and osteoporosis therapeutic effect and use thereof
EP3663313A4 (en) N-terminal recombinant protein of ccr4 and usage thereof
ZA202105277B (en) Compositions comprising amino acids for use and treatment of central nervous system injuries
EP4031174A4 (en) Human anti-pd-l1 peptide vaccines and methods of their use
IL272074A (en) Peptide compounds and methods of treating diseases using same
EP3836949A4 (en) Compositions comprising sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith
EP3682891A4 (en) Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
EP3682892A4 (en) Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
EP4087595A4 (en) Peptide compositions and methods of use thereof